Using 3D Transesophageal Echocardiography to Choose Device Size for Closing Atrial Septal Defect without Balloon Sizing
Led by Asan Medical Center · Updated on 2025-02-07
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of three-dimensional transesophageal echocardiography to select the correct device size for closing atrial septal defects ASD without using a sizing balloon. The study aims to confirm the accuracy of a previously developed formula for device size prediction and improve the procedure for ASD patients. This research is sponsored by Asan Medical Center and focuses on patients aged 18 to 80 who are candidates for device closure.
Participants undergo transcatheter device closure where the device size is chosen using the three-dimensional echocardiographic images combined with the formula, avoiding the use of a sizing balloon. This method is being evaluated for its effectiveness in ensuring successful device implantation during the procedure.
During the study, researchers will measure the success of device implantation within one day after the procedure and record procedure time. Participants will be monitored closely to assess outcomes related to the device closure process. The study started in March 2014 and is expected to continue until December 2026, involving adult patients who meet the eligibility criteria.
CONDITIONS
Brief Title
Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
Research Team
J
Jong-Min Song, MD,PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Poor candidate for device closure, such as having multiple atrial septal defects
Presence of other heart diseases requiring open heart surgery
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Implementation
Duration - Procedure day
Participants undergo transcatheter device closure of the atrial septal defect using three-dimensional imaging to select device size without a sizing balloon.
1 procedure visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Post-Market Follow-Up Study of the Lifetech Cera10 ASD Occluder
for Long-Term Safety and Performance in Atrial Septal Defect Treatment
Study of Brain Microembolism After Closing Patent Foramen Ovale or Atrial Septal Defect Using Catheter Devices
Using 3D Transesophageal Echocardiography to Choose Device Size for Closing Atrial Septal Defect without Balloon Sizing
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Routine application of three-dimensional transesophageal echocardiography-based device selection for transcatheter closure of atrial septal defect without balloon sizing.